Fundraising Fox

Israel Innovation Authority

Government fund

Jerusalem · Pre-Seed–Series A

Fox Verdict
Sign up to see your fit
Stage
Pre-Seed–Series A
Check
$140K – $5M
HQ
Jerusalem, IL
Instruments
Equity · Grants

Frequently asked questions

What stage does Israel Innovation Authority invest at?
Israel Innovation Authority invests at the Pre-Seed, Seed, Series A stages.
What is Israel Innovation Authority's typical check size?
Israel Innovation Authority typically writes checks of $140K – $5M.
What sectors does Israel Innovation Authority focus on?
Israel Innovation Authority focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Healthtech.
Where is Israel Innovation Authority located?
Israel Innovation Authority is headquartered in Jerusalem, IL.

Similar investors

DCVC (Data Collective)

DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.

Innovestor Ventures

Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.

$270K – $3.2M
Khosla Ventures

Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.

$5K – $50M
Fundamental Ventures

Fundamental Ventures backs founders attacking fundamental constraints across hard tech, deep science, and industry-rewiring innovations. The firm combines domain depth and execution pattern recognition to support companies breaking through physical, biological, and operational limits.

1955 Capital

1955 Capital invests in early-stage companies emerging from scientific breakthroughs in biology, materials, and computation. The firm focuses on translating foundational science into scalable commercial enterprises, partnering closely with founders and scientists from discovery through growth.

Featured in lists